Please Wait.....
Report
Global Small Molecule API Market Report and Forecast 2024-2032
Market Report I 2023-09-15 I 160 Pages I EMR Inc.
Global Small Molecule API Market Report and Forecast 2024-2032
Global Small Molecule API Market Outlook
The Small Molecule API market was valued USD 195.6 billion in 2023, driven by increasing healthcare needs, a growing aging population, the prevalence of chronic diseases, and ongoing drug innovation has led to market growth across the globe. The market size is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032 to achieve a value of USD 352.7 billion by 2032.
Small Molecule API: Introduction
A Small Molecule API (Active Pharmaceutical Ingredient) refers to the chemical compound or molecule that is responsible for the therapeutic effect in a pharmaceutical drug. These small molecules are typically organic compounds with a relatively low molecular weight. They form the basis of many pharmaceutical drugs and are designed to interact with specific target molecules in the body to produce a desired therapeutic effect. Common examples of pharmaceutical drugs based on small molecule APIs include pain relievers like aspirin, antibiotics like penicillin, and cholesterol-lowering statins.
Small molecule APIs represent a significant portion of the pharmaceutical industry and have contributed to the development of numerous important drugs that treat a wide range of medical conditions. The discovery, development, and production of small molecule APIs involve a multidisciplinary approach, including chemistry, biology, pharmacology, and regulatory expertise
Key Trends in the Small Molecule API Market
- Increased Focus on Personalized Medicine: Advances in genomics and molecular biology have led to a growing emphasis on personalized medicine. Small molecule APIs can be tailored to specific genetic profiles or disease characteristics, allowing for more targeted and effective treatments. This trend is likely to continue as researchers gain a better understanding of the genetic basis of diseases.
- Rise of Biopharmaceuticals: While small molecule APIs remain important, the biopharmaceutical sector, which includes protein-based drugs and antibodies, has been growing rapidly. However, small molecules continue to play a crucial role in drug development, especially for diseases that can be effectively treated with small molecule interventions.
- Technological Advances in Drug Discovery: Advancements in computational biology, artificial intelligence, and high-throughput screening have revolutionized drug discovery. These technologies enable researchers to identify potential small molecule APIs more efficiently and predict their interactions with target molecules, saving time and resources.
- Focus on Rare Diseases: The orphan drug market, which includes drugs for rare diseases, has seen increased attention. Small molecule APIs that target specific rare diseases have gained traction due to regulatory incentives and the unmet medical needs of patients with these conditions.
Global Small Molecule Api Market Segmentation
The market can be categorised into type, therapeutic type, manufacturing method, applications, and region.
Market Breakup by type
- Synthetic/Chemical API
- Biological API
Market Breakup by Therapeutic Type
- Autoimmune Diseases
- Oncology
- Metabolic Diseases
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Dermatology
- Urology
- Others
Market Breakup by Manufacturing Method
- In-House
- Contract
Market Breakup by Applications
- Clinical
- Commercial
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Small Molecule Api Market Overview
Small molecule API (Active Pharmaceutical Ingredient) market has been a significant segment of the pharmaceutical industry. Small molecule APIs serve as the core components of many pharmaceutical drugs, driving the development of various therapeutic treatments. The small molecule API market has been experiencing steady growth due to factors such as increasing healthcare needs, a growing aging population, the prevalence of chronic diseases, and ongoing drug innovation. The market size is substantial, with a wide range of small molecule APIs being utilized in pharmaceutical products across various therapeutic areas.
Small molecule APIs are manufactured on a global scale, with production facilities distributed across different regions. Certain countries and regions, such as India and China, have been known for their significant contributions to API manufacturing due to cost-effectiveness and technical expertise.
The small molecule API market faces challenges related to increasing regulatory requirements, supply chain disruptions, and the need for continuous innovation. However, advancements in technology, personalized medicine, and increased focus on rare diseases present opportunities for growth and development.
Key Players in the Small Molecule API Market
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in small molecule api market are as follows:
- Albemarle Corporation
- Allergan
- Aurobindo Pharma
- Cambrex Corporation
- Dr. Reddy's Laboratories Ltd.
- GSk plc.
- Lonza
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Siegfried Holding AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Johnson Matthey
- Gilead Sciences, Inc.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1Preface
1.1Objectives of the Study
1.2Key Assumptions
1.3Report Coverage - Key Segmentation and Scope
1.4Research Methodology
2Executive Summary
3Global Small Molecule API Market Overview
3.1Global Small Molecule API Market Historical Value (2017-2023)
3.2Global Small Molecule API Market Forecast Value (2024-2032)
4Global Small Molecule API Market Landscape
4.1Global Small Molecule API Developers Landscape
4.1.1Analysis by Year of Establishment
4.1.2Analysis by Company Size
4.1.3Analysis by Region
4.2Global Small Molecule API Product Landscape
4.2.1Analysis by Type
4.2.2Analysis by Therapeutic Type
4.2.3Analysis by Applications
5Global Small Molecule API Market Dynamics
5.1Market Drivers and Constraints
5.2SWOT Analysis
5.3Porter's Five Forces Model
5.4Key Demand Indicators
5.5Key Price Indicators
5.6Industry Events, Initiatives, and Trends
5.7Value Chain Analysis
6Global Small Molecule API Market Segmentation
6.1Global Small Molecule API Market by Type
6.1.1Market Overview
6.1.2Synthetic/Chemical API
6.1.3Biological API
6.2Global Small Molecule API Market by Therapeutic Type
6.2.1Market Overview
6.2.2Autoimmune Diseases
6.2.3Oncology
6.2.4Metabolic Diseases
6.2.5Ophthalmology
6.2.6Cardiovascular Diseases
6.2.7Infectious Diseases
6.2.8Neurology
6.2.9Respiratory Disorders
6.2.10Dermatology
6.2.11Urology
6.2.12Others
6.3Global Small Molecule API Market by Manufacturing Method
6.3.1Market Overview
6.3.2In-House
6.3.3Contract
6.4Global Small Molecule API Market by Applications
6.4.1Market Overview
6.4.2Clinical
6.4.3Commercial
6.5Global Small Molecule API Market by Region
6.5.1Market Overview
6.5.2North America
6.5.3Europe
6.5.4Asia Pacific
6.5.5Latin America
6.5.6Middle East and Africa
7North America Small Molecule API Market
7.1Market Share by Country
7.2United States of America
7.3Canada
8Europe Small Molecule API Market
8.1Market Share by Country
8.2United Kingdom
8.3Germany
8.4France
8.5Italy
8.6Others
9Asia Pacific Small Molecule API Market
9.1Market Share by Country
9.2China
9.3Japan
9.4India
9.5ASEAN
9.6Australia
9.7Others
10Latin America Small Molecule API Market
10.1Market Share by Country
10.2Brazil
10.3Argentina
10.4Mexico
10.5Others
11Middle East and Africa Small Molecule API Market
11.1Market Share by Country
11.2Saudi Arabia
11.3United Arab Emirates
11.4Nigeria
11.5South Africa
11.6Others
12Patent Analysis
12.1Analysis by Type of Patent
12.2Analysis by Publication year
12.3Analysis by Issuing Authority
12.4Analysis by Patent Age
12.5Analysis by CPC Analysis
12.6Analysis by Patent Valuation
12.7Analysis by Key Players
13Grants Analysis
13.1Analysis by year
13.2Analysis by Amount Awarded
13.3Analysis by Issuing Authority
13.4Analysis by Grant Application
13.5Analysis by Funding Institute
13.6Analysis by NIH Departments
13.7Analysis by Recipient Organization
14Funding Analysis
14.1Analysis by Funding Instances
14.2Analysis by Type of Funding
14.3Analysis by Funding Amount
14.4Analysis by Leading Players
14.5Analysis by Leading Investors
14.6Analysis by Geography
15Partnership and Collaborations Analysis
15.1Analysis by Partnership Instances
15.2Analysis by Type of Partnership
15.3Analysis by Leading Players
15.4Analysis by Geography
16Regulatory Framework
16.1Regulatory Overview
16.1.1US FDA
16.1.2EU EMA
16.1.3INDIA CDSCO
16.1.4JAPAN PMDA
16.1.5Others
17Supplier Landscape
17.1Albemarle Corporation
17.1.1Financial Analysis
17.1.2Product Portfolio
17.1.3Demographic Reach and Achievements
17.1.4Mergers and Acquisition
17.1.5Certifications
17.2Allergan
17.2.1Financial Analysis
17.2.2Product Portfolio
17.2.3Demographic Reach and Achievements
17.2.4Mergers and Acquisition
17.2.5Certifications
17.3Aurobindo Pharma
17.3.1Financial Analysis
17.3.2Product Portfolio
17.3.3Demographic Reach and Achievements
17.3.4Mergers and Acquisition
17.3.5Certifications
17.4Cambrex Corporation
17.4.1Financial Analysis
17.4.2Product Portfolio
17.4.3Demographic Reach and Achievements
17.4.4Mergers and Acquisition
17.4.5Certifications
17.5Dr. Reddy's Laboratories Ltd.
17.5.1Financial Analysis
17.5.2Product Portfolio
17.5.3Demographic Reach and Achievements
17.5.4Mergers and Acquisition
17.5.5Certifications
17.6GSk plc.
17.6.1Financial Analysis
17.6.2Product Portfolio
17.6.3Demographic Reach and Achievements
17.6.4Mergers and Acquisition
17.6.5Certifications
17.7Lonza
17.7.1Financial Analysis
17.7.2Product Portfolio
17.7.3Demographic Reach and Achievements
17.7.4Mergers and Acquisition
17.7.5Certifications
17.8Merck KGaA
17.8.1Financial Analysis
17.8.2Product Portfolio
17.8.3Demographic Reach and Achievements
17.8.4Mergers and Acquisition
17.8.5Certifications
17.9Novartis AG
17.9.1Financial Analysis
17.9.2Product Portfolio
17.9.3Demographic Reach and Achievements
17.9.4Mergers and Acquisition
17.9.5Certifications
17.10Pfizer Inc.
17.10.1Financial Analysis
17.10.2Product Portfolio
17.10.3Demographic Reach and Achievements
17.10.4Mergers and Acquisition
17.10.5Certifications
17.11Siegfried Holding AG
17.11.1Financial Analysis
17.11.2Product Portfolio
17.11.3Demographic Reach and Achievements
17.11.4Mergers and Acquisition
17.11.5Certifications
17.12Sun Pharmaceutical Industries Ltd.
17.12.1Financial Analysis
17.12.2Product Portfolio
17.12.3Demographic Reach and Achievements
17.12.4Mergers and Acquisition
17.12.5Certifications
17.13Teva Pharmaceutical Industries Ltd.
17.13.1Financial Analysis
17.13.2Product Portfolio
17.13.3Demographic Reach and Achievements
17.13.4Mergers and Acquisition
17.13.5Certifications
17.14Johnson Matthey
17.14.1Financial Analysis
17.14.2Product Portfolio
17.14.3Demographic Reach and Achievements
17.14.4Mergers and Acquisition
17.14.5Certifications
17.15Gilead Sciences, Inc.
17.15.1Financial Analysis
17.15.2Product Portfolio
17.15.3Demographic Reach and Achievements
17.15.4Mergers and Acquisition
17.15.5Certifications
18Global Small Molecule API Market - Distribution Model (Additional Insight)
18.1Overview
18.2Potential Distributors
18.3Key Parameters for Distribution Partner Assessment
19Key Opinion Leaders (KOL) Insights (Additional Insight)
20Company Competitiveness Analysis (Additional Insight)
20.1Very Small Companies
20.2Small Companies
20.3Mid-Sized Companies
20.4Large Companies
20.5Very Large Companies
21Payment Methods (Additional Insight)
21.1Government Funded
21.2Private Insurance
21.3Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security